Stocks
AnaptysBio (ANAB) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -55.7 | -105.3 | -156.4 | -92.7 | 50.3 | 52.7 | |
| Changes by years, y/y, % | +188% | +89% | +49% | -41% | -154% | |||
AnaptysBio. EBITDA US GAAP, bln rub
AnaptysBio. EBITDA US GAAP, changes, %
AnaptysBio. EBITDA US GAAP, sum by quarters, bln rub
AnaptysBio (ANAB) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -20.6 | -18.4 | 38.2 | 67.5 | -34.6 | 52.7 | |
| Changes by years, y/y, % | -44% | -48% | -327% | -1 874% | +68% | |||
| Changes by quarters, q/q, % | +442% | -11% | -308% | +77% | -151% | |||
